ShockWave Medical is a medical device company. Co. provides a new standard of care for medical device treatment of atherosclerotic cardiovascular disease through its local delivery of sonic pressure waves for the treatment of calcified plaque, which Co. refers to as intravascular lithotripsy (IVL). Co.'s products for treatment of peripheral artery disease (PAD) include its Shockwave M5 IVL catheter and M5+ IVL catheter for the treatment of above-the-knee PAD; and Shockwave S4 IVL catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. Co.'s product for the treatment of coronary artery disease includes its Shockwave C2 IVL catheter. The SWAV average annual return since 2019 is shown above.
The Average Annual Return on the SWAV average annual return since 2019 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SWAV average annual return since 2019 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SWAV average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|